Acadia Healthcare (NASDAQ:ACHC) Sets New 52-Week High After Analyst Upgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price reached a new 52-week high during trading on Wednesday after TD Cowen raised their price target on the stock from $30.00 to $36.00. TD Cowen currently has a buy rating on the stock. Acadia Healthcare traded as high as $32.93 and last traded at $32.86, with a volume of 727492 shares traded. The stock had previously closed at $31.60.

Several other equities analysts also recently issued reports on the stock. Royal Bank Of Canada raised their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Barclays upped their price target on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, April 30th. Finally, Guggenheim increased their price target on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $28.69.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Wellington Management Group LLP grew its stake in Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after purchasing an additional 2,350,760 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after buying an additional 3,815,471 shares in the last quarter. UBS Group AG boosted its holdings in shares of Acadia Healthcare by 8.8% during the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after buying an additional 350,484 shares in the last quarter. Jefferies Financial Group Inc. acquired a new stake in shares of Acadia Healthcare during the 4th quarter worth approximately $47,960,000. Finally, Invenomic Capital Management LP increased its stake in shares of Acadia Healthcare by 71.0% in the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after acquiring an additional 1,375,647 shares in the last quarter.

Acadia Healthcare Stock Up 4.6%

The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The stock’s 50-day moving average is $26.28 and its 200-day moving average is $22.12. The company has a market cap of $3.04 billion, a price-to-earnings ratio of -2.70, a P/E/G ratio of 10.19 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same period last year, the company posted $0.40 earnings per share. The business’s quarterly revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.